The Malaysian Reserve

U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ ...

Updated indication allows the use of RINVOQ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom ...